These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1085 related items for PubMed ID: 18824005

  • 1. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP, Bryson S, Nieva JL, Pai EF.
    J Mol Biol; 2008 Dec 12; 384(2):377-92. PubMed ID: 18824005
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 3. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R, Huarte N, Julien JP, Kunert R, Pai EF, Nieva JL.
    AIDS Res Hum Retroviruses; 2011 Aug 17; 27(8):863-76. PubMed ID: 21142698
    [Abstract] [Full Text] [Related]

  • 4. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A, Chow KC, Pan OC, Scott JK.
    J Mol Biol; 2004 Apr 23; 338(2):311-27. PubMed ID: 15066434
    [Abstract] [Full Text] [Related]

  • 5. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS, Pattenden LK, Fletcher JM, Castanho MA, Aguilar MI.
    Chembiochem; 2009 Apr 17; 10(6):1032-44. PubMed ID: 19283693
    [Abstract] [Full Text] [Related]

  • 6. Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5.
    de la Arada I, Julien JP, de la Torre BG, Huarte N, Andreu D, Pai EF, Arrondo JL, Nieva JL.
    J Phys Chem B; 2009 Oct 15; 113(41):13626-37. PubMed ID: 19754136
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB, Citron M, Danzeisen RC, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller M, Shiver J, Bogusky MJ.
    Biochemistry; 2003 Mar 25; 42(11):3214-23. PubMed ID: 12641452
    [Abstract] [Full Text] [Related]

  • 8. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope.
    Fiebig U, Schmolke M, Eschricht M, Kurth R, Denner J.
    AIDS; 2009 May 15; 23(8):887-95. PubMed ID: 19414989
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
    Hinz A, Schoehn G, Quendler H, Hulsik DL, Stiegler G, Katinger H, Seaman MS, Montefiori D, Weissenhorn W.
    Virology; 2009 Aug 01; 390(2):221-7. PubMed ID: 19539967
    [Abstract] [Full Text] [Related]

  • 10. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
    Sánchez-Martínez S, Lorizate M, Hermann K, Kunert R, Basañez G, Nieva JL.
    FEBS Lett; 2006 Apr 17; 580(9):2395-99. PubMed ID: 16616522
    [Abstract] [Full Text] [Related]

  • 11. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA.
    Immunity; 2005 Feb 17; 22(2):163-73. PubMed ID: 15723805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.
    Ou W, Lu N, Yu SS, Silver J.
    J Virol; 2006 Mar 17; 80(5):2539-47. PubMed ID: 16474160
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu, Kuvshinov VN, Azaev MSh, Masharskiĭ AE, Klimov NA, Kozlov AP, Il'ichev AA, Sandakhchiev LS.
    Mol Biol (Mosk); 2001 Mar 17; 35(1):146-51. PubMed ID: 11234374
    [Abstract] [Full Text] [Related]

  • 16. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
    Luftig MA, Mattu M, Di Giovine P, Geleziunas R, Hrin R, Barbato G, Bianchi E, Miller MD, Pessi A, Carfí A.
    Nat Struct Mol Biol; 2006 Aug 17; 13(8):740-7. PubMed ID: 16862157
    [Abstract] [Full Text] [Related]

  • 17. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.
    Cardoso RM, Brunel FM, Ferguson S, Zwick M, Burton DR, Dawson PE, Wilson IA.
    J Mol Biol; 2007 Feb 02; 365(5):1533-44. PubMed ID: 17125793
    [Abstract] [Full Text] [Related]

  • 18. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J, Wyatt RT.
    PLoS Pathog; 2012 Feb 02; 8(7):e1002806. PubMed ID: 22829767
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.